Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Seth Cohen
University of Texas, Austin, Department: Pharmacology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Forge Therapeutics
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Cohen submitted an update of financial interest for Forge Therapeutics (Forge). Dr. Cohen’s interests as a founder of Forge, member of the Scientific Advisory Board and equity interest have already been reviewed by the Independent Review Committee on Conflict of Interest and the management plan has been reported to the prime awardee. Dr. Cohen now receives income in the amount of (b)(4) for consulting with the company. Forge utilizes a novel chemistry platform to target metalloenzymes. The project proposes to characterize selected compounds for their ability to restore carbapenem sensitivity to a panel of bacteria harboring metallo-beta-lactamase resistance determinants.
Developing Metallo-Beta-Lactamase Inhibitors
The New Delhi Metallo-�-lactamase-1 (NDM-1) is the primary antibiotic resistance determinant in several emerging `superbugs.' Discovery of NDM-1 inhibitors will help us better understand this enzyme and will jumpstart development of new drugs. Therefore, the work is relevant to the mission of NIH to pursue fundamental knowledge, to reduce the burden of human illness, and combat an emerging global public health threat.
Filed on June 11, 2018.
Tell us what you know about Seth Cohen's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Seth Cohen filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Seth Cohen | University of California, San Diego | Conflict of Interest | Cleave Biosciences | $20,000 - $39,999 |
| Seth Cohen | University of California, San Diego | Conflict of Interest | Forge Therapeutics | $10,000 - $19,999 |
| Seth Cohen | University of Texas, Austin | Conflict of Interest | Forge Therapeutics | $10,000 - $19,999 |
| Seth Cohen | University of California, San Diego | Conflict of Interest | Forge Therapeutics | $0 - $4,999 |
| Seth Cohen | University of California, San Diego | Conflict of Interest | Cleave Biosciences | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.